Ofer Shamni

Title: Ofer Shamni: Innovator in Radiolabeled Compounds

Introduction

Ofer Shamni is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of medical research, particularly in the development of radiolabeled compounds. His work focuses on enhancing the capabilities of radioimaging and radiotherapy.

Latest Patents

Ofer Shamni holds a patent for "Radiolabeled erlotinib analogs and uses thereof." This patent discloses radiolabeled compounds that are erlotinib analogs featuring a radioactive halogen. The processes for preparing these compounds are also detailed. The uses of these radiolabeled compounds include radioimaging for identifying and monitoring the level, distribution, and mutational status of deregulated EGFR, as well as applications in radiotherapy.

Career Highlights

Ofer Shamni is associated with Hadasit Medical Research Services and Development Ltd., where he continues to advance his research. His innovative work has the potential to significantly impact cancer treatment and diagnostics.

Collaborations

Ofer collaborates with notable colleagues, including Eyal Yosef Mishani and Galith Rachel Abourbeh-Gofrit. Their combined expertise contributes to the success of their research initiatives.

Conclusion

Ofer Shamni's contributions to the field of radiolabeled compounds exemplify the importance of innovation in medical research. His work not only enhances diagnostic capabilities but also paves the way for improved therapeutic strategies.